Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted
The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled.
Full Article
Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted
NYTimes.com
0 shares
1 views
You might like
Related news coverage
Malaria drug fails to prevent COVID-19 in a rigorous study
A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality..
SeattlePI.com